Surgical and multimodality treatment of cardiac sarcomas: A systematic review and meta-analysis.
Saeed TorabiArian Arjomandi RadRobert VardanyanAleksandra T LopuszkoJef Van den EyndeAlina ZubarevichMichel P B O SáMarcin Piotr SzczechowiczAlexander WeymannPublished in: Journal of cardiac surgery (2021)
Overall, surgery was found to provide a significant mortality advantage to PCS patients up to 3 years following treatment. Multimodality treatment might be of additional benefit, although only within the first year. Prospective randomized studies are needed to further explore these differences in the treatment of PCS.